Bloed- en weefselcentrum in Zuid-Texas markeert drie maanden gebruik van de geavanceerde oplossing van Biolog-id ter ondersteuning van de productie en distributie van COVID-19 herstellend plasma

ATLANTA– (BUSINESS WIRE) – Biolog-id, LLC, een wereldleider in verbonden oplossingen voor bloedproducten, en het South Texas Blood & Tissue Center, een toonaangevende leverancier van bloedproducten in heel Zuid-Texas en daarbuiten, markeren drie maanden van succesvol gebruik van Biolog-id’s speciale Convalescent Plasma-oplossing in de supply chain. De geïmplementeerde oplossing biedt real-time zichtbaarheid van herstellend plasma van verzameling tot distributie, stroomlijnt de voorraad, verbetert de efficiëntie en maximaliseert uiteindelijk het rendement op donatie. Een betere zichtbaarheid van de inventaris vergemakkelijkt een efficiënt beheer van herstellend plasma en verhoogt zo de beschikbaarheid van deze schaarse en waardevolle antilichamen voor de COVID-19-patiënten die ze nodig hebben.

“Het was essentieel voor ons team om ervoor te zorgen dat de oplossing van Biolog-id zich kon aanpassen aan snelle veranderingen in productie, regelgeving en marktomstandigheden voor deze unieke productcategorie”, zegt Elizabeth Waltman, Chief Operating Officer bij South Texas Blood & Tissue Center. “Drie maanden later kunnen we volledig beseffen hoe belangrijk die flexibiliteit was voor ons bloedcentrum en voor de COVID-19-patiënten die op ons vertrouwen.”

Biolog-id Empowers South Texas Blood & Tissue Center’s Response to COVID-19

South Texas Blood & Tissue Center Marks Three Months of Using Biolog-id’ s Cutting-Edge Solution Supporting the Manufacturing and Distribution of COVID-19 Convalescent Plasma

ATLANTA–(BUSINESS WIRE)– Biolog-id, LLC, a world leader in connected solutions for blood products, and South Texas Blood & Tissue Center, a leading provider of blood products throughout South Texas and beyond, mark three months of successful utilization of Biolog-id’s dedicated Convalescent Plasma solution in its supply chain. The deployed solution provides real-time visibility to convalescent plasma from collection to distribution, streamlining inventory, improving efficiency, and ultimately maximizing Return on Donation. Better visibility to the inventory facilitates efficient management of convalescent plasma, and so increases the availability of these scarce and valuable antibodies to the COVID-19 patients who need them.

“It was key for our team to ensure that Biolog-id’s solution could adapt to rapid changes in manufacturing, regulation, and market conditions for this unique product category,” said Elizabeth Waltman, Chief Operating Officer at South Texas Blood & Tissue Center. “Three months later we can fully appreciate how important that flexibility was for our blood center and for the COVID-19 patients that rely on us.”

“In addressing the need for a Convalescent Plasma solution, we used an inside-the-box approach to innovation,” said Amit Mayer, VP Innovation & Analytics at Biolog-id LLC. “This allowed us to leverage existing elements of our hardware, software, and industry know-how to rapidly develop a robust solution for a completely new type of blood product.”

“Our culture of collaboration meshed well with the needs of South Texas Blood & Tissue Center and their desire to positively influence patient outcomes.,” said Troy L. Hilsenroth, CEO Biolog-id LLC. “The solution we have deployed demonstrates our joint commitment to find new and better ways to track, store, and distribute high-value products in healthcare.”

About Biolog-id

Biolog-id has developed a patented smart solution for the management and traceability of sensitive, high-value health products throughout the hospital supply chain to ensure safe delivery from donor to patient. Biolog-id operates in North America, Europe, Middle East, India and Asia Pacific region and has 90 employees worldwide. Biolog-id is owned by its founder, managers, and the Xerys Funds.

Company URL: www.biolog-id.com

About South Texas Blood & Tissue Center

The South Texas Blood & Tissue Center (STBTC) is a nonprofit community blood center that provides blood, plasma, platelets and other blood components to 100 hospitals in 48 South Texas counties. It is the largest blood supplier in the region. In addition, it recovers and distributes donated human tissue for transplant. STBTC has a 45-year history serving the South Texas community. It is part of the BioBridge Global family of nonprofit organizations, which offers services in regenerative medicine and research including blood banking and resource management; cellular therapy; umbilical cord blood collection and storage; donated human tissue recovery and distribution for transplant; and testing of blood and plasma products to help patients in the United States and worldwide. STBTC has seven donor rooms in South Texas and conducts hundreds of mobile blood drives each year. STBTC is online at SouthTexasBlood.org.

Company URL: www.southtexasblood.org

View source version on businesswire.com: https://www.businesswire.com/news/home/20200723005067/en/

Contacts

Amit Mayer, amit.mayer@biolog-id.com